IRIS publication 160959112
Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia
RIS format for Endnote and similar
TY - - Other - Langabeer, SE,Crampe, M,Haslam, K,Kelly, J,Cahill, MR - 2010 - January - Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia - Validated - 1 - () - CHRONIC MYELOGENOUS LEUKEMIA TRANSCRIPTS RECOMMENDATIONS P190(BCR-ABL) - 176 - 177 - DOI 10.1016/j.leukres.2010.01.025 DA - 2010/01 ER -
BIBTeX format for JabRef and similar
@misc{V160959112,
= {Other},
= {Langabeer, SE and Crampe, M and Haslam, K and Kelly, J and Cahill, MR },
= {2010},
= {January},
= {Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia},
= {Validated},
= {1},
= {()},
= {CHRONIC MYELOGENOUS LEUKEMIA TRANSCRIPTS RECOMMENDATIONS P190(BCR-ABL)},
pages = {176--177},
= {DOI 10.1016/j.leukres.2010.01.025},
source = {IRIS}
}Data as stored in IRIS
| OTHER_PUB_TYPE | Other | ||
| AUTHORS | Langabeer, SE,Crampe, M,Haslam, K,Kelly, J,Cahill, MR | ||
| YEAR | 2010 | ||
| MONTH | January | ||
| TITLE | Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia | ||
| RESEARCHER_ROLE | |||
| STATUS | Validated | ||
| PEER_REVIEW | 1 | ||
| TIMES_CITED | () | ||
| SEARCH_KEYWORD | CHRONIC MYELOGENOUS LEUKEMIA TRANSCRIPTS RECOMMENDATIONS P190(BCR-ABL) | ||
| REFERENCE | |||
| ABSTRACT | |||
| PUBLISHER_LOCATION | |||
| PUBLISHER | |||
| EDITORS | |||
| ISBN_ISSN | |||
| EDITION | |||
| URL | |||
| START_PAGE | 176 | ||
| END_PAGE | 177 | ||
| DOI_LINK | DOI 10.1016/j.leukres.2010.01.025 | ||
| FUNDING_BODY | |||
| GRANT_DETAILS |